Julien Patris
Julien Patris
Contributor, The Yuan

Julien Patris is Head of Policy for International Markets and Country Manager for Belgium and Luxembourg at Alnylam Pharmaceuticals. 

Success of future biotech innovation to hinge on various factors
New Era
A Nobel laureate MIT professor and a medtech exec talk up how COVID-19 has reshaped attitudes toward public health, fiscal policy, and the state’s economic role, and of how demands for greater supply-chain resilience and autonomy in making medicines have spawned the concept of ‘life-science sovereignty.’
Phillip A. Sharp, Julien Patris  |  Jun 16, 2022